PI3K News
Most Popular PI3K Story
Roche licenses key cancer biomarker from Qiagen
Swiss pharma powerhouse Roche has inked a co-exclusive license on Qiagen's PI3K (phosphoinositide 3-kinase) biomarker so it can proceed with the development of new diagnostic assays. Johns Hopkins Read more...
Latest Headlines
Roche licenses key cancer biomarker from Qiagen
Swiss pharma powerhouse Roche has inked a co-exclusive license on Qiagen's PI3K (phosphoinositide 3-kinase) biomarker so it can proceed with the development of new diagnostic assays. Johns Hopkins Read more...
